-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Bz9+8JcLQGpehhVE8xbx3fO57zz/rb6/lAvh37HGOW1C+jSZTn+sMfx1VLD9m44K YoKOEUEHDP/AnxjbFXy+ZA== 0000950123-95-003585.txt : 19951205 0000950123-95-003585.hdr.sgml : 19951205 ACCESSION NUMBER: 0000950123-95-003585 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 19951128 ITEM INFORMATION: Other events ITEM INFORMATION: Financial statements and exhibits FILED AS OF DATE: 19951204 SROS: NYSE FILER: COMPANY DATA: COMPANY CONFORMED NAME: MERCK & CO INC CENTRAL INDEX KEY: 0000064978 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221109110 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-03305 FILM NUMBER: 95598922 BUSINESS ADDRESS: STREET 1: ONE MERCK DR STREET 2: P O BOX 100 CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889-0100 BUSINESS PHONE: 9084234044 MAIL ADDRESS: STREET 1: ONE MERCK DR STREET 2: PO BOX 100 WS3AB-05 CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889-0100 8-K 1 MERCK & CO., INC. FORM 8-K 1 SECURITIES & EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 28, 1995 ------------------------------- MERCK & CO., Inc. - -------------------------------------------------------------------------------- (Exact name of registrant as specified in its charter) New Jersey - -------------------------------------------------------------------------------- (State or other jurisdiction of incorporation) 1-3305 22-1109110 ------------------------ --------------------------------- (Commission File Number) (IRS Employer Identification No.) One Merck Drive, PO Box 100, Whitehouse Station, NJ 08889-0100 - -------------------------------------------------------------------------------- (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code (908) 423-1000 ----------------------------- 2 Item 5. Other Events Incorporated by reference is that portion of a press release issued by the Registrant on November 28, 1995 concerning the Registrant's announcement of the approval by its Board of Directors of a new $3 billion treasury stock purchase program. The press release is attached as Exhibit 99. Item 7. Financial Statements and Exhibits (c) Exhibit Exhibit 99 - Press release issued November 28, 1995. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. MERCK & CO., Inc. By: /s/ Nancy V. Van Allen ------------------------------- Nancy V. Van Allen Assistant Secretary December 4, 1995 3 EXHIBIT INDEX
Method Exhibit of Number Description Filing - ------- ----------- ------ 99 Press release issued November 28, 1995. Filed with this document.
EX-99 2 PRESS RELEASE ISSUED NOVEMBER 28, 1995 1 Exhibit 99 FOR IMMEDIATE RELEASE Contacts: John Doorley, Press Contact Whitehouse Station, N.J. -- (908) 423-4081 Home -- (908) 232-2052 Jim Hinrichs, Investor Contact Whitehouse Station, N.J. -- (908) 423-6883 MERCK BOARD DECLARES DIVIDEND AND APPROVES $3 BILLION TREASURY STOCK PURCHASE PROGRAM WHITEHOUSE STATION, NJ, November 28, 1995 -- The Board of Directors of Merck & Co., Inc., in two separate actions today, declared a quarterly dividend of 34 cents a share and approved a new $3 billion treasury stock purchase program. The Board declared a quarterly dividend of 34 cents a share on the Company's common stock for the first quarter of 1996. The 34-cent dividend is payable January 2, 1996 to stockholders of record at the close of business on December 8, 1995. The Board of Directors of Merck & Co., Inc. today also approved purchases over time of up to an additional $3 billion of its common stock for its treasury. The Company is currently completing purchases under a November 1994, $2 billion authorization. Through September 30, 1995 the Company spent $1.3 billion to acquire 29 million shares under the November 1994, $2 billion authorization. Under prior approvals during the period 1985 through 1994, the Company spent $4.7 billion to acquire 223 million shares of its stock on the open market. Merck currently has approximately 1,230 million shares outstanding. - more - 2 - 2 - Treasury stock purchases will be made on the open market in block transactions and in privately negotiated transactions. Purchases may be suspended from time to time or discontinued. Shares acquired will be available for use under the Company's employee benefit programs and for other general corporate purposes. Merck & Co., Inc. is a leading research-driven pharmaceutical products and services company. Merck discovers, develops, manufacturers and markets a broad range of innovative products to improve human and animal health. The Merck-Medco Managed Care Division manages pharmacy benefits for employers, insurers and other plan sponsors, encouraging the appropriate use of medicines and providing disease management programs. Through these complementary capabilities, Merck works to improve quality of life and contain overall health-care costs. ### -----END PRIVACY-ENHANCED MESSAGE-----